11/7/26 Mock Formal FDA Meeting: How to Respond When FDA Disagrees Previous Accelerated Pathways and Global Harmonization Next Practical Application of Bayesian Networks in Rare Disease Trials You Might Also Like OPENING KEYNOTE - From Breakthrough to Access: How Advocacy and Policy Decide What Reaches Patients. Patient Organizations as Evidence Partners: Shaping the Science Behind Rare Disease Approval Accelerated Pathways and Global Harmonization One Shot, No Slack: The Clinical Decisions That Make or Break a Rare Disease Program Platform and Basket Trials in Rare Disease: What’s Working, What Isn’t, and What It Takes to Scale
11/7/26 Mock Formal FDA Meeting: How to Respond When FDA Disagrees Previous Accelerated Pathways and Global Harmonization Next Practical Application of Bayesian Networks in Rare Disease Trials You Might Also Like OPENING KEYNOTE - From Breakthrough to Access: How Advocacy and Policy Decide What Reaches Patients. Patient Organizations as Evidence Partners: Shaping the Science Behind Rare Disease Approval Accelerated Pathways and Global Harmonization One Shot, No Slack: The Clinical Decisions That Make or Break a Rare Disease Program Platform and Basket Trials in Rare Disease: What’s Working, What Isn’t, and What It Takes to Scale
